0001179110-12-007746.txt : 20120504
0001179110-12-007746.hdr.sgml : 20120504
20120504125755
ACCESSION NUMBER: 0001179110-12-007746
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20110620
FILED AS OF DATE: 20120504
DATE AS OF CHANGE: 20120504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HICKMAN WINSTON E
CENTRAL INDEX KEY: 0001245444
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21123
FILM NUMBER: 12813170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SRS LABS INC
CENTRAL INDEX KEY: 0001016470
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 330714264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2909 DAIMIER ST
CITY: SANTA ANA
STATE: CA
ZIP: 92705
BUSINESS PHONE: 9494421070
MAIL ADDRESS:
STREET 1: 2909 DAIMLER ST
CITY: SANTA ANA
STATE: CA
ZIP: 92705
4/A
1
edgar.xml
FORM 4/A -
X0305
4/A
2011-06-20
2011-06-21
0
0001016470
SRS LABS INC
SRSL
0001245444
HICKMAN WINSTON E
C/O SRS LABS, INC.
2909 DAIMLER STREET
SANTA ANA
CA
92705
1
0
0
0
Employee Stock Option
8.72
2011-06-20
4
A
0
25000
0
A
2012-06-20
2021-06-19
Common Stock
25000
25000
D
Nonqualified stock option grant under the SRS Labs, Inc. 2006 Stock Incentive Plan. The option shall vest as follows: 1/4th to vest one year after the date of grant and 1/16th every three months during the next three successive years thereafter measured from June 20, 2012.
This amendment corrects the description of the vesting terms in the originally filed Form 4.
/s/Gloria Ciancio, attorney-in-fact for Winston E. Hickman
2012-05-04
EX-24
2
ex24-whickman.txt
POWER OF ATTORNEY
Know all men by these presents, that the undersigned hereby constitutes
and appoints Thomas C.K. Yuen, Walter McBride and Gloria Ciancio, and each of
them, signing singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as a greater than 10% stockholder
and/or an officer and/or director of SRS Labs, Inc. (the
"Company"), all statements or reports under Section 16 of the
Securities Exchange Act of 1934, as amended (the "Exchange
Act") and the rules thereunder with respect to the beneficial
ownership of the securities issued by the Company, including,
without limitation, all initial statements of beneficial
ownership on Form 3, all statements or changes of beneficial
ownership on Form 4, and all annual statements of beneficial
ownership on Form 5 and all other documents that may be
required from time to time (including, without limitation, all
amendments and supplemental to any such statements, documents
or forms), to be filed with the United States Securities and
Exchange Commission (the "Commission");
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
and execute any such Form 3, 4, 5 or such other document as
may be required from time to time and timely file such
statements, documents and forms with the Commission and any
stock exchange, or other similar authority; and
(3) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of any such
attorney-in-fact, may be of benefit to, in the opinion of any
such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being
understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Form 3, 4, 5 or other like documents
as may be required from time to time with respect to the undersigned's holdings
of and transactions in securities issued by the Company, or unless earlier
revoked by the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 30th day of November 2011.
---------------------------------
Winston Hickman
CONFIRMING STATEMENT
This statement confirms that the undersigned, WINSTON HICKMAN, has
authorized Thomas C.K. Yuen, Walter McBride and Gloria Ciancio, and each of
them, signing singly, to execute and file on the undersigned's behalf all Forms
3, 4, and 5 (including any amendments thereto) that the undersigned may be
required to file with the U.S. Securities and Exchange Commission as a result of
the undersigned's ownership of or transactions in securities of SRS Labs, Inc.
The authority of Thomas C.K. Yuen, Walter McBride and Gloria Ciancio under this
statement shall continue until the undersigned is no longer required to file
Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions
in securities of SRS Labs, Inc., unless earlier revoked in writing. The
undersigned acknowledges that Thomas C.K. Yuen, Walter McBride and Gloria
Ciancio are not assuming any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
Dated as of November 30, 2011
-----------------------------
Winston Hickman